By Chris Temple of The National Investor
Wall Street’s Best Investments Editor’s Note: An FDA panel has not yet given its seal of approval to Sarepta Therapeutics new muscular dystrophy drug—the final FDA hearing is scheduled for the end of May. Meanwhile, Chris Temple us...
Every year, I ask our contributors to Wall Street’s Best Dividend Stocks and Wall Street’s Best Investments to select the one investment that they believe will be their biggest winner that year. And earlier this month, I published the winners in our special Picks...
While two of the three broad market indices fell on hard times in 2015, the top four recommendations in our 2015 Top Picks issue gave subscribers some excellent gains! For the year, the Dow Jones Industrial Average lost -2.24%, the S&P 500 was -0.73%...
In today’s Daily Alert, Chris Temple recommends a specialized REIT with a 6% yield, and David Dittman provides an update on one of his MLPs.
Universal Health Realty Income Trust (UHT)
from The National Investor
Universal Health REIT (UHT), an owner of more than 50 facilities 15...
In today’s Daily Alert The National Investor Editor Chris Temple recommends a value-priced mortgage REIT currently yielding a whopping 13.3%.
“Annaly Capital Management, Inc. (NLY, NYSE) is one of the largest and best known names among mortgage-related real estate investment trusts (REITs). But it been...
April 25 Investment Digest Daily Alert
I hope you’re enjoying yesterday’s new Investment Digest issue. Today’s Daily Alert
brings a follow-up on a low-priced pharmaceutical company recommended in
the Digest in past years. Below, Chris Temple says it’s time to take profits on his
wildly successful recommendation.
In today's Stock Market Crash Course, the experts say the market still looks strong, but there are some signs things are deteriorating under the surface. Volume, the VIX and stocks making new highs are all suggesting a correction ahead. Experts quoted include Stephen Rick...